Preeclampsia/Hypertensive disorders of pregnancy

Hypertensive disorders of pregnancy are the most common and dangerous pregnancy complications where both mother and fetus may be severely affected.

Definitions and epidemiology

Hypertension, defined as a blood pressure exceeding 140 mmHg (systolic) and/ or 90 mmHg (diastolic), affects approximately 10% of pregnancies world-wide.
  1. Chronic hypertension in pregnancy affects 1-2% of pregnancies in the Nordic countries. It is defined as hypertension detected before the pregnancy, or during first 20 weeks of pregnancy (women normally decrease their blood pressure in the first trimester). Some of women with chronic hypertension will also develop proteinuria and their pregnancy is then characterized with “superimposed preeclampsia”.
  2. Gestational hypertension (GH, in Europe also named pregnancy induced hypertension-PIH) affects 4-5% of pregnancies in Norway, and is defined by new-onset hypertension presenting after gestational week (GW) 20. About 20% of GH pregnancies will later in pregnancy develop proteinuria, and therefore the pregnancy is defined as preeclamptic.
  3. Preeclampsia(PE) affects approximately 3-4% of pregnancies in the Nordic countries and is traditionally defined as new-onset hypertension and proteinuria detected after GW 20. As researchers and clinicians are now acknowledging the clinical heterogeneity of preeclampsia, women with new-onset hypertension after GW 20 can also be defined as preeclamptics without new-onset proteinuria, in the situation where she also has new onset of other preeclampsia-related signs, such as HELLP (hemolysis, elevated liver enzymes, low plates), eclampsia, visual/cerebral affection etc.
  4. Eclampsia is a rare form of preeclampsia, affecting 5 in 10 000 pregnancies in Scandinavia. It is defined as general seizures that occur during pregnancy (40%), delivery (30%) or the first week after delivery (30%), when it coexists with a hypertensive pregnancy disease and where there is found no other neurological causes for the seizure. Magnesium sulphate is the drug of choice.

Pathophysiology of preeclampsia

Preeclampsia requires the presence of placenta tissue, but the maternal predisposition (e.g. obesity, chronic hypertension, chronic renal disease, multiple pregnancy etc) also plays a significant role. For some, especially the early-onset for of preeclampsia with preterm delivery, there is an incomplete development of the maternoplacental circulation (spiral arteries). Central to the development of the maternal disease is an excessive systemic maternal vascular inflammation with vascular (endothelial) dysfunction, secondary to inflammatory substances shed from a dysfunctional placenta (due to malperfusion of the placenta). Preeclampsia is syndromic in its nature, explained by its widespread effect on many organs.

Symptoms and signs

The following SYMPTOMS (patient subjective) or SIGNS (objective findings) may indicate severe features of preeclampsia (and are therefore indications for contacting the doctor/hospital).
SymtomsClinical signsLabExplanation: why could preeclampsia (PE) cause this?
Severe headache, visual disturbance/flashesFoot clonusMay indicate prodromal stage of eclampsia
Reduced fetal movementsAdverse CTG/ DopplerMay indicate severe placental dysfunction (frequent in early-onset preeclampsia, but also possible at term preeclampsia)
Strong abdominal painElevated liver enzymes, low platelets, signs of hemolysis (LD)Epigastric or upper right quadrant: may indicate HELLP (hemolysis, elevated liver enzymes, low platelets)/ liver disease or rupture.
Any part of the abdomen: may indicate abruptio placenta (detachment of the placenta prior to delivery: the risk of this in preeclampsia is elevated due to placenta pathology)
Very rapid weight gainVery severe hand/leg and face edemasElevated hematocritSevere preeclampsia pathology includes severe endothelial dysfunction and excessive leakage of fluid into tissues
DyspnoaAbnormal lung sounds (rales, crackles)Decreased oxygen saturationPreeclampsia increases the risk of lung edema, same reason as above.
Also increased, is the risk of deep venous thrombosis/lung embolus due to higher thrombosis predisposition due to excessive activation of the endothelium.
Vascular shockExcessive maternal hemorrhage during/after deliveryDecreased fibrinogen platelet levels and platelet counts Increased risk of bleeding due to low platelet counts as well as platelet dysfunction (either isolated, or part of HELLP), secondary to microcirculation and endothelial dysfunction

Patient information

Do you know what to do if you measure hypertension and proteinuria in a pregnant woman? When to refer her to the hospital? What to tell her?

This film may illustrate some of the key points. Antihypertensive therapy is started in women with preeclampsia when blood pressure is ≥ 150/100.

Film: Preeclampsia long-term follow-up” “Film: Preeklampsi langtidsoppfølging

Are you able to answer the questions below from the patient? Some tips on how to respond are suggested.

• What is preeclampsia, and what is the role of the placenta? Show tips
You may want to present some of the following key points:
• Why did I get preeclampsia? Show tips
You may want to present some of the following key points:
• How will you follow up my pregnancy given that I have preeclampsia? Show tips
You may want to present some of the following key points:
• How to prevent preeclampsia in next pregnancy? Show tips
You may want to present some of the following key points:
• Has preeclampsia long-term effects on my own health or my baby’s health? Show tips
You may want to present some of the following key points:

Click for movie in English: Preeclampsia long-term follow-upKlikk for film på norsk: Preeklampsi langtidsoppfølging

Information brochure (for layman and health officers) on Preeclampsia and future health, in English or Norwegian. 

Take-home messages: gestational hypertension /preeclampsia
  1. Any pregnant woman may develop gestational hypertension (GH) /preeclampsia (PE)
  2. Regular antenatal visits are essential for diagnosing GH/PE
  3. Antihypertensive therapy reduces risk for maternal cerebral hemorrhage, but does not treat the primary problem of placental dysfunction